May 05, 2020
Akebia Therapeutics Announces Positive Top-Line Results from Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
Feb 24, 2020
Erythropoietic Protoporphyria - Pipeline Insight, 2020
Jan 03, 2020
Global Recombinant Cell Culture Supplements Markets, 2019-2029: Rising Demand for Monoclonal Antibodies and Stem Cell Research
Nov 27, 2019
The Erythropoietin Stimulating Agents Market in Latin America (2019-2027): Data on Epoetin-Alfa, Epoetin-Beta, Epoetin-Theta, Darbepoetin-Alfa, and Other ESAs
Sep 24, 2019
Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Patients
Sep 16, 2019
China Recombinant Human Thrombopoietin Markets, 2013-2017, 2017-2018 & 2019-2023
Jul 01, 2019
Neuralstem Announces Publication of Results from Phase 1 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Patients
Jun 24, 2019
Shionogi Concludes Licensing Agreements with Eddingpharm for Lusutrombopag, a Thrombopoietin Receptor Agonist
Feb 13, 2019
Renal Anemia Treatment Market Will Reach at a CAGR of 7.5% Through 2026: Persistence Market Research
Jan 14, 2019
Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study of epoCat(TM) for the Management of Non-Regenerative Anemia in Cats and Availability of Mirataz® at Banfield Pet Hospital
Jan 07, 2019
Stemedica Cell Technologies Reports Positive Data in Phase I/IIa Study of Allogeneic Stem Cells for Ischemic Stroke
Jul 31, 2018
Pfizer's Retacrit, the First Erythropoietin Stimulating Agent to be FDA Approved, Not Likely to See Rapid Adoption in the US Dialysis Market
May 31, 2018
Biosimilars in Nephrology: Pfizer's Retacrit Gets FDA Clearance and Prepares to Challenge Amgen's Anemia Franchise Head On
May 15, 2018
FDA approves first epoetin alfa biosimilar for the treatment of anemia
May 08, 2018
The US Renal Anemia Market Sees Some Shifting As Mircera Use Expands Beyond Fresenius Medical Care Clinics and Auryxia Makes its Debut with a New Iron Deficiency Anemia Indication in the Pre-Dialysis Setting
Feb 07, 2018
Global Erythropoietin Drugs Market 2017-2025 by Drug & Application Type - A $19.65 Billion Market Opportunity
Dec 07, 2017
Erythropoietin Drugs Market Value to Reach US$19,379.2 Million by the end of 2025: Transparency Market Research
Jun 22, 2017
Erythropoietin (EPO) Drugs Market to Reach $17.4 Billion by 2025 - Number of People Suffering From Anemia Expected to Increase - Research and Markets
Jun 22, 2017
Erythropoietin Drugs Market Size Worth $17.4 Billion by 2025: Grand View Research, Inc.
Jun 20, 2017
Erythropoietin (EPO) Drugs Market is expected to reach USD 17.4 billion by 2025